SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors) such as empagliflozin, dapagliflozin, and canagliflozin represent excellent alternatives, providing cardiovascular and renal protection alongside modest weight loss (typically 2-4 kg)
The average age of those 47 patients was 39 years old, with a range of 1571 years old
Exenatide, the active ingredient in Bydureon BCise, was the first GLP-1 medication to be approved by the FDA
--- Track Your IGF-1 LR3 Protocol With PeptIQ IGF-1 LR3 cycles require discipline: exact timing, dose tracking, blood glucose logs, and cycle/off-cycle records
Factors like age-related loss of elasticity and a decrease in muscle mass can further contribute to this effect, making the arms appear less toned
This potential benefit appears to work through multiple pathways